| Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ER Garrido, ... Arthritis & Rheumatism 46 (8), 2121-2131, 2002 | 1302 | 2002 |
| Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study M Tunca, S Akar, F Onen, H Ozdogan, O Kasapcopur, F Yalcinkaya, ... Medicine (Baltimore) 84 (1), 1-11, 2005 | 995 | 2005 |
| EULAR recommendations for the management of Behçet disease G Hatemi, A Silman, D Bang, B Bodaghi, AM Chamberlain, A Gul, ... Annals of the rheumatic diseases 67 (12), 1656-1662, 2008 | 994 | 2008 |
| 2018 update of the EULAR recommendations for the management of Behçet’s syndrome G Hatemi, R Christensen, D Bang, B Bodaghi, AF Celik, F Fortune, ... Annals of the Rheumatic Diseases 77 (6), 808-818, 2018 | 764 | 2018 |
| Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease EF Remmers, F Cosan, Y Kirino, MJ Ombrello, N Abaci, C Satorius, JM Le, ... Nature genetics 42 (8), 698-702, 2010 | 758 | 2010 |
| The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide FA Houssiau, C Vasconcelos, D D’Cruz, GD Sebastiani, ... Annals of the rheumatic diseases 69 (01), 61-64, 2010 | 593 | 2010 |
| Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B* 51 and ERAP1 Y Kirino, G Bertsias, Y Ishigatsubo, N Mizuki, I Tugal-Tutkun, E Seyahi, ... Nature genetics 45 (2), 202-207, 2013 | 587 | 2013 |
| Prevalence of Behçet's disease in Istanbul, Turkey G Azizlerli, A Akdağ Köse, R Sarıca, A Gül, İT Tutkun, M Kulaç, R Tunç, ... International journal of dermatology 42 (10), 803-806, 2003 | 562 | 2003 |
| Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease Q Zhou, H Wang, DM Schwartz, M Stoffels, YH Park, Y Zhang, D Yang, ... Nature genetics 48 (1), 67-73, 2016 | 547 | 2016 |
| Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ... Arthritis & rheumatism 50 (12), 3934-3940, 2004 | 466 | 2004 |
| Canakinumab for the treatment of autoinflammatory recurrent fever syndromes F De Benedetti, M Gattorno, J Anton, E Ben-Chetrit, J Frenkel, ... New England Journal of Medicine 378 (20), 1908-1919, 2018 | 434 | 2018 |
| Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations PP Sfikakis, N Markomichelakis, E Alpsoy, S Assaad-Khalil, B Bodaghi, ... Rheumatology 46 (5), 736-741, 2007 | 430 | 2007 |
| Behcet's disease: an update on the pathogenesis A Gul Clinical and experimental rheumatology 19 (5; SUPP/24), S-6, 2001 | 418 | 2001 |
| Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease … I Tugal‐Tutkun, A Mudun, M Urgancioglu, S Kamali, E Kasapoglu, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2005 | 406 | 2005 |
| Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study … JL Mege, N Dilsen, V Sanguedolce, A Gul, P Bongrand, H Roux, L Ocal, ... The Journal of rheumatology 20 (9), 1544-1549, 1993 | 361 | 1993 |
| Familial aggregation of Behcet's disease in Turkey A Gül, M Inanç, L Öcal, O Aral, M Koniçe Annals of the rheumatic diseases 59 (8), 622-625, 2000 | 349 | 2000 |
| Classification criteria for autoinflammatory recurrent fevers M Gattorno, M Hofer, S Federici, F Vanoni, F Bovis, I Aksentijevich, ... Annals of the rheumatic diseases 78 (8), 1025-1032, 2019 | 347 | 2019 |
| Pulmonary manifestations of Behçet's disease F Erkan, A Gül, E Tasali Thorax 56 (7), 572-578, 2001 | 340 | 2001 |
| COVID‐19 is a Real Headache! H Bolay, A Gül, B Baykan Headache: The Journal of Head and Face Pain 60 (7), 1415-1421, 2020 | 332 | 2020 |
| Induced-pluripotent-stem-cell-derived primitive macrophages provide a platform for modeling tissue-resident macrophage differentiation and function K Takata, T Kozaki, CZW Lee, MS Thion, M Otsuka, S Lim, KH Utami, ... Immunity 47 (1), 183-198. e6, 2017 | 309 | 2017 |
